Chanelle Lai

Research Interests

Biological Sciences Host-Parasite Interactions Cellular Interactions Cell Biology Biochemistry & Molecular Biology Science Communication

Teaching Strengths

Practical Demonstrating
Transparent marking criteria
Student-centred and inclusive teaching
Adapting teaching methods based on feedback
Adaptive Teaching Strategies

Miss Chanelle Lai

Higher Degree by Research Candidate

School of Biological Sciences

College of Science

Available For Media Comment.

Malaria is a disease caused by apicomplexan parasites that results in severe disease and death. There are currently multiple strategies deployed, including chemotherapies and vector controls, to combat malaria with limited efficiency. In particular, vaccinations currently available against clinical malaria that are currently available provide limited protection, which wanes over time. Hence, novel vaccine candidates are required to help improve the protective efficacy of vaccines against malaria. In my project, I assess the functional role of merozoite surface proteins PfMSP1, PfMSP2, PvMSP3, PfMSP9 and PfMSP10s in invasion and immunogenicity. These outcomes will aid in prioritising merozoite surface proteins as promising candidates for a malaria vaccine.

Date Position Institution name
2023 - ongoing Practical Demonstrator The University of Adelaide
2022 - 2022 Research Assistant The University of Adelaide

Language Competency
Chinese (Cantonese) Can read, write, speak and understand spoken
Chinese (Mandarin) Can read, write, speak and understand spoken
Malay Can read, write, speak and understand spoken

Date Institution name Country Title
2022 - 2022 The University of Adelaide Australia Bachelor of Science (Honours)
2022 - 2021 The University of Adelaide Australia Bachelor of Science (Biomedical Science)

Year Citation
2026 Seager, B. A., Lim, P. S., Xiao, X., Lai, K. H., Feufack-Donfack, L. B., Dass, S., . . . Scally, S. W. (2026). PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of Plasmodium species into erythrocytes.. Nat Commun, 17(1), 17 pages.
DOI Scopus2 WoS1 Europe PMC4
2026 Henshall, I. G., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K. R., . . . Wilson, D. W. (2026). An abundant merozoite surface protein of 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘧𝘢𝘭𝘤𝘪𝘱𝘢𝘳𝘶𝘮 modulates susceptibility to inhibitory antibodies.. eLife, 14, RP107603-1-RP107603-29.
DOI
2026 Henshall, I. G., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K. R., . . . Wilson, D. W. (2026). An abundant merozoite surface protein of 𝘗𝘭𝘢𝘴𝘮𝘰𝘥𝘪𝘶𝘮 𝘧𝘢𝘭𝘤𝘪𝘱𝘢𝘳𝘶𝘮 modulates susceptibility to inhibitory antibodies. eLife, 14, RP107603-1-RP107603-29.
DOI
2024 Angage, D., Chmielewski, J., Maddumage, J. C., Hesping, E., Caiazzo, S., Lai, K. H., . . . Foley, M. (2024). A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites. Nature Communications, 15(1), 7206-1-7206-17.
DOI Scopus6 WoS7 Europe PMC8
- Henshall, I. G., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K. R., . . . Wilson, D. W. (2026). An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies. eLife, 14.
DOI

Year Citation
2025 Seager, B. A., Lim, P. S., Lai, K. H., Feufack-Donfack, L. B., Dass, S., Xiao, X., . . . Cowman, A. F. (2025). PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of Plasmodium species into erythrocytes..
DOI
2025 Cowman, A., Seager, B., Lim, P., Lai, K. -H., Feufack-Donfack, L., Dass, S., . . . Scally, S. (2025). PTRAMP, CSS and Ripr form a conserved complex required for merozoite invasion of Plasmodium species into erythrocytes..
DOI
2025 Henshall, I. G., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K. R., . . . Wilson, D. W. (2025). An abundant merozoite surface protein of Plasmodium falciparum modulates susceptibility to inhibitory antibodies.
DOI
2025 Henshall, I., Chmielewski, J., Angage, D., Romeo, O., Lai, K. H., Turland, K., . . . Wilson, D. (2025). An abundant merozoite surface protein of <i>Plasmodium falciparum</i> modulates susceptibility to inhibitory antibodies.
DOI Europe PMC1
2023 Foley, M., Angage, D., Anders, R., Chmielewski, J., Maddumage, J., Hesping, E., . . . Boddey, J. (2023). A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites.
DOI

MBS Prac Series (A, B, C)

HAP1B Prac (Microbiology component)

Date Role Committee Institution Country
2024 - ongoing Representative Adelaide Protein Group Australian Society for Biochemistry and Molecular Biology Australia

Date Role Membership Country
2024 - ongoing Member Australian Society for Biochemistry and Molecular Biology Australia
2023 - ongoing Member Institute for Photonics and Advanced Sensing Australia
2022 - ongoing Member Australian Society for Parasitology Australia

Connect With Me

External Profiles

Other Links